Princeton Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $651K | Buy |
|
|||||
|
2025
Q1 | $772K | Sell |
|
|||||
|
2024
Q4 | $880K | Sell |
|
|||||
|
2024
Q3 | $1.31M | Sell |
|
|||||
|
2024
Q2 | $1.35M | Buy |
|
|||||
|
2024
Q1 | $859K | Buy |
|
|||||
|
2023
Q4 | $753K | Buy |
|
|||||
|
2023
Q3 | $694K | Hold |
|
|||||
|
2023
Q2 | $606K | Buy |
|
|||||
|
2023
Q1 | $623K | Sell |
|
|||||
|
2022
Q4 | $558K | Hold |
|
|||||
|
2022
Q3 | $533K | Buy |
|
|||||
|
2022
Q2 | $448K | Hold |
|
|||||
|
2022
Q1 | $529K | Sell |
|
|||||
|
2021
Q4 | $489K | Buy |
|
|||||
|
2021
Q3 | $415K | Hold |
|
|||||
|
2021
Q2 | $383K | Buy |
|
|||||
|
2021
Q1 | $318K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $74K | Hold |
|
|||||
|
2019
Q2 | $83K | Hold |
|
|||||
|
2019
Q1 | $109K | Sell |
|
|||||
|
2018
Q4 | $103K | Sell |
|
|||||
|
2018
Q3 | $191K | Sell |
|
|||||
|
2018
Q2 | $1.13M | Sell |
|
|||||
|
2018
Q1 | $1.15M | Sell |
|
|||||
|
2017
Q4 | $1.39M | Buy |
|